EXAS (Exact Sciences Inc.) Operating Sales Margin

Exact Sciences - graphic logo of issuer EXAS

Exact Sciences relies on the expanding early cancer diagnostics sector and the growing number of insured patients. However, dependence on a single product and pressure from Medicare regulators create financial risks. Prospects are tied to the rollout of Cologuard Plus and the transition to profitability. The operating margin level visualizes business efficiency, and the value of -4.80 shows the current magnitude of this metric.

exactsciences.com (EXAS): Profitability of Operations from 07/04/2022 to 04/04/2026

EXAS (Exact Sciences): analytical breakdowns and indicator data

Fundamental company analysis:EXAS, Exact Sciences
Finished products of Exact Sciences Inc.

Steady demand for non-invasive cancer diagnostics and insurance coverage generate a predictable revenue stream for Exact Sciences (EXAS), despite significant marketing expenditures. The current operating margin reflects the share of profit from core operations before interest and taxes, allowing investors to assess cost management efficiency and the company's actual capital cushion amid market volatility.

Competing companies

Operating Sales Margin A|DGX: Operating Profit Rate|Operating Margin ILMN|Operating Profit Ratio RVTY|Bio-Rad - Operating Sales Margin|Anbio - Operating Profitability|soterahealth.com - Operating Margin|Operating Profit Rate QDEL (QuidelOrtho)|OPK (OPKO Corp) - Operating Sales Margin|Return on Sales by Operating Profit CDNA|MRVI (Maravai LifeSciences Holdings) - Operating Margin|Operating Return on Sales Fulgent Genetics Inc FLGT|Operating Profitability fluidigm.com (LAB)|Operating Sales Margin Cytek Bio CTKB|Operating Margin OSUR (OraSure Technologies)|Operating Profitability Margin Exagen Inc.|MDXH - Operating Profitability|Profitability of Operations Lucid Diagnostics Inc LUCD|PRE: Operating Margin|Insight Molecular (IMDX) - Operating Margin|TRIB (trinitybiotech.com) - Operating Margin|prophaselabs.com (PRPH) - Profitability of Operations|Operating Margin AIMD|Profitability of Operations Co-Diagnostics Inc|Operating Margin HSCS (Heart Test Laboratories, Inc.)|Operating Profit Rate BMRA|CDIO - Operating Profitability|Operating Return on Sales onconetix.gcs-web.com|Virax Biolabs Group (VRAX) - Operating Profitability|BJDX - Profitability of Operations|AWH (Aspira Women's Health, Inc.) - Operating Margin|Accelerate Diagnostics, Inc (AXDX) - Profitability of Operations|Operating Margin CNTG|ENZ - Operating Return on Sales|Operating Profit Rate Fresh2 Group Ltd|Genetic Technologies (GENE) - Operating Return on Sales|ME - Operating Profitability|Profitability of Operations Psychemedics Corp PMD